MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Successful late rehabilitation based on botulinum therapy

T. Kuznetsova, A. Svetkina (Samara, Russian Federation)

Meeting: 2019 International Congress

Abstract Number: 1374

Keywords: Aphasia, Botulinum toxin: Clinical applications: spasticity, Rehabilitation

Session Information

Date: Tuesday, September 24, 2019

Session Title: Spasticity

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: Hemiparesis of various severity is the most common stroke side effect. On average 30-40% of stroke survivors develop post-stroke spasticity. The best neuroplasticity enabling full functional recovery is preserved within 3 months after stroke; afterward rehabilitation is widely considered inefficient. This case study breaks down the stereotypical time frame of efficient rehabilitation and describes high brain neuroplasticity many years after CVA.

Background: In 2002 a 23-year-old patient developed a MCA stroke (caused by primary APS) with severe speech (Broca’s aphasia) and movement (right-sided spastistic hemiparesis) disorders. During the following 13 years the patient has undergone numerous speech and physical therapy courses, however, these only provided short-term relief with no significant neurological improvement. In 2015 the patient was first complexly assessed with the following baseline results: neuropsychological status (J.M. Grozman scale, 0 [best] to 4 [worst]): dynamic praxis – 3, propositional speech – 2,5, non-propositional speech – 2,5, speech perception – 1; Frenchay arm test – 1, pain intensity (VAS scale) – 8, functional status (FIM scale) – 54.

Method: The 3-year treatment course included ultrasound-guided botulinumtoxinA injections into spastic muscles every 4 months combined with daily speech therapy and physical exercises suggested in Guided Self-Rehabilitation concept by J.-M. Gracies.

Results: Follow-up assessment in 2016 revealed substantial progress in neuropsychological status. The patient regained simple-structured language skills. Paralyzed limbs exhibited improved motor function, long-term pain in the paresis shoulder ceased. Due to enhanced movement control the patient was able to go swimming and took prizes in nationwide  contests.Second follow-up in 2018 showed even more progress by all scales, with enhanced fine motor skills and phrase speech. The patient was able to read simple words, speech perception impairment reduced. [table1]

Conclusion: Treatment results in this case cannot be attributed to spontaneous recovery. Speech recovery was based on relation between voluntary movement disorder and motor speech disorder caused by Broca’s aphasia. BotulinumtoxinA-treatment contributed to patient’s well-being and pain relief which led to increase in motor function and consequently to speech rehabilitation 16 years after the stroke. This proves long-term brain neuroplasticity enabling late recovery after acute CVA.

Table1

To cite this abstract in AMA style:

T. Kuznetsova, A. Svetkina. Successful late rehabilitation based on botulinum therapy [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/successful-late-rehabilitation-based-on-botulinum-therapy/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/successful-late-rehabilitation-based-on-botulinum-therapy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley